The Food and Drug Administration is warning doctors and patients about counterfeit surgical mesh being illegally marketed under the C.R. Bard brand name. The FDA has identified thirteen lots of Bard Flat Mesh that were not actually made by the company. The counterfeit products come in four sizes. For the Latest information regarding on World News or Stock Market Info, make sure to visit the Most Exclusive and In Depth newsletter website at: http://www.wallstreetgrand.com/.
Join today and be part of the best free investment newsletter on the web where we focus on market moving news.
The Food and Drug Administration is warning doctors and patients about counterfeit surgical mesh being illegally marketed under the C.R. Bard (NYSE:BCR) brand name. The FDA has identified thirteen lots of Bard Flat Mesh that were not actually made by the company. The counterfeit products come in four sizes. The agency said in a statement it has not determined whether the mesh is safe for use. Surgical mesh is used to reinforce soft tissue following an operation. Doctors should carefully monitor patients for adverse effects if they have potentially received the affected products.
Consumers who think they have counterfeit products can call Bard at 800-556-6275.
You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.
Disclaimer:
Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.
